Literature DB >> 15164373

The older sickle cell patient.

Thomas D H McKerrell1, Hillel W Cohen, Henny H Billett.   

Abstract

The lifespan of sickle cell patients has increased substantially. We chose to compare the attributes of older sickle cell patients with younger ones within the confines of a single institutional study serving the local Bronx population. Laboratory and clinical assessments from 40 patients with sickle cell disease over 40 years of age were compared to 40 patients under 30 years of age. When the older group was compared to the younger group, hemoglobin, indirect bilirubin, and platelet counts were significantly lower. Creatinine clearances were lower and BUN levels were higher in the older group. Although the prevalence of radiographically measured cardiomegaly was significantly higher in the older group, systolic and diastolic blood pressures remained unchanged. The number of crises and number of admissions were higher in the younger group than in the older, but there was wide variation, and no significant differences could be detected; days spent in hospital over the previous 2 years did not differ. No statistically significant differences were observed for absolute reticulocyte count, MCV, % HbF, white cell count, liver function tests, or oxygen saturation. Comparing genders within age groups, younger males had higher hemoglobin levels and absolute reticulocyte counts than younger females, while only the older females had higher HbF levels than the corresponding males. Lower levels of hemoglobin associated with older age may reflect decreased hematopoietic potential that may in part be due to decreased renal function. Lower platelet counts in older sickle cell patients may be a consequence of this decreased hematopoietic potential but may also represent a secondary survival benefit effect in sickle cell anemia. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164373     DOI: 10.1002/ajh.20075

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

2.  Renal status of children with sickle cell disease in Accra, Ghana.

Authors:  C T Osei-Yeboah; O Rodrigues
Journal:  Ghana Med J       Date:  2011-12

3.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

4.  A multi-institutional comparison of younger and older adults with sickle cell disease.

Authors:  Charity Oyedeji; John Joseph Strouse; Regina D Crawford; Melanie E Garrett; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2019-01-31       Impact factor: 10.047

Review 5.  How I treat the older adult with sickle cell disease.

Authors:  Swee Lay Thein; Jo Howard
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

6.  Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?

Authors:  Eugene E Harris; Avelin A Malyango
Journal:  BMC Med Educ       Date:  2005-05-10       Impact factor: 2.463

7.  Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease.

Authors:  Susanna A Curtis; Neeraja Danda; Zipora Etzion; Hillel W Cohen; Henny H Billett
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

8.  Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project.

Authors:  Donna K McClish; Wally R Smith; James L Levenson; Imoigele P Aisiku; John D Roberts; Susan D Roseff; Viktor E Bovbjerg
Journal:  Biomed Res Int       Date:  2017-03-28       Impact factor: 3.411

9.  Elevated Steady State WBC and Platelet Counts Are Associated with Frequent Emergency Room Use in Adults with Sickle Cell Anemia.

Authors:  Susanna A Curtis; Neeraja Danda; Zipora Etzion; Hillel W Cohen; Henny H Billett
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

10.  Selenium Status and Hemolysis in Sickle Cell Disease Patients.

Authors:  Emília Delesderrier; Cláudia S Cople-Rodrigues; Juliana Omena; Marcos Kneip Fleury; Flávia Barbosa Brito; Adriana Costa Bacelo; Josely Correa Koury; Marta Citelli
Journal:  Nutrients       Date:  2019-09-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.